Marshall Wace North America’s Pediatrix Medical MD Stock Holding History

Marshall Wace North America’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,716	Closed	-$337K	–	1464
2020 Q3	$337K	Buy	20,716 +10,444	+102%	+$194K	﹤0.01%	1047
2020 Q2	$175K	Sell	10,272 -4,241	-29%	-$62.9K	﹤0.01%	1080
2020 Q1	$169K	Sell	14,513 -40,660	-74%	-$839K	﹤0.01%	925
2019 Q4	$1.53M	Buy	55,173 +44,439	+414%	+$1.11M	0.01%	629
2019 Q3	$243K	Buy	+10,734	New	+$245K	﹤0.01%	928
2019 Q1	–	Sell	-2,777	Closed	-$92K	–	1761
2018 Q4	$92K	Sell	2,777 -19,710	-88%	-$792K	﹤0.01%	1098
2018 Q3	$1.05M	Buy	+22,487	New	+$1.03M	0.01%	602
2018 Q2	–	Sell	-173,987	Closed	-$9.68M	–	1560
2018 Q1	$9.68M	Sell	173,987 -503,278	-74%	-$27.6M	0.05%	400
2017 Q4	$36.2M	Buy	677,265 +421,349	+165%	+$19.9M	0.2%	119
2017 Q3	$11M	Buy	255,916 +157,387	+160%	+$7.48M	0.07%	343
2017 Q2	$5.91M	Buy	+98,529	New	+$5.84M	0.04%	454

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Marshall Wace North America's MD Position: Q4 2020 in Review

Marshall Wace North America sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 20,716 shares — an estimated $337K sold.

Marshall Wace North America first reported a position in MD in Q2 2017 and held it in 11 quarters. The position peaked at $36.2M in Q4 2017. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

Marshall Wace North America reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 20,716 Pediatrix Medical shares in Q4 2020, an estimated $337K.
Marshall Wace North America first reported a position in Pediatrix Medical in Q2 2017 and held it in 11 quarters.
Marshall Wace North America's Pediatrix Medical position peaked at $36.2M in Q4 2017.
201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.